Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
This article was originally published in The Tan Sheet
Executive Summary
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.